HDL- HDL- GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT

摘要

The present invention provides methods and compositions for the analysis of genetic traits for selecting patients with cardiovascular disease who benefit from treatment with HDL-elevated or HDL-mimicking agents, particularly CETP inhibitors / regulators.